SUVEN LIFE SCIENCES
Back to All Ratios
|
SUVEN LIFE SCIENCES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | -7.10 | -4.52 | -5.12 | -7.45 | -4.91 |
What is the latest Cash Earnings per Share (CEPS) ratio of SUVEN LIFE SCIENCES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | -7.10 |
| Mar2024 | -4.52 |
| Mar2023 | -5.12 |
| Mar2022 | -7.45 |
| Mar2021 | -4.91 |
How is Cash Earnings per Share (CEPS) of SUVEN LIFE SCIENCES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | -7.1 | Negative | |
| Mar2024 | -4.52 | Negative | |
| Mar2023 | -5.12 | Negative | |
| Mar2022 | -7.45 | Negative | |
| Mar2021 | -4.91 | - | |
Other Financial Ratios of SUVEN LIFE SCIENCES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹3,623.2 Cr | -4.6% | -9.7% | 15.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,693.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,270.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,281.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,422.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹104,915.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -4.6% |
-9.7% |
15.2% |
| SENSEX | -2.7% |
-10.4% |
1.6% |
You may also like the below Video Courses